Filing Details
- Accession Number:
- 0001415889-24-016107
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-07 21:45:08
- Reporting Period:
- 2024-05-29
- Accepted Time:
- 2024-06-07 21:45:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1231457 | Genelux Corp | GNLX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1937525 | Mary Mirabelli | C/O Genelux Corporation 2625 Townsgate Road, Suite 230 Westlake Village CA 91361 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-29 | 8,000 | $0.00 | 12,460 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Warrant (Right to Buy) | Acquisiton | 2024-05-29 | 8,000 | $0.00 | 8,000 | $5.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,000 | 2024-05-29 | 2029-05-29 | No | 4 | P | Direct |
Footnotes
- The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock. The combined price of each share of common stock offered together with one warrant was $4.00.
Billionaire Hedge Funds
